Before intervention (95% CI)* | ||||||||
---|---|---|---|---|---|---|---|---|
Penicillin-V | Amoxicillin | Amoxicillin-Clavulanic acid | Macrolide | Quinolone | Tetracycline | Cephalosporin | Other | |
Argentina | 15.3 (8.2-22.4) | 54.7 (38.3-71.1) | 16.9 (5.0-28.8) | 2.3 (0.7-4.5) | 1.5 (0-3.0) | 0.1 (0-0.4) | 4.1 (0-8.5) | 10.0 (0-21.1) |
Denmark | 79.6 (74.0-85.3) | 9.2 (5.9-12.6) | 0.2 (0-0.5) | 7.2 (4.7-9.8) | 0.2 (0-0.5) | 0.2 (0-0.5) | 0 (0-0) | 3.9 (0.3-7.5) |
Lithuania | 24.2 (16.7-31.8) | 37.6 (26.0-49.1) | 18.1 (13.3-22.8) | 6.5 (4.2-8.9) | 0 (0-0) | 1.8 (0-3.8) | 10.9 (4.5-17.4) | 0.8 (0-1.6) |
Russia | 9.0 (3.4-14.6) | 42.5 (31.3-53.8) | 29.2 (18.6-39.8) | 14.1 (5.8-22.3) | 1.9 (0-4.0) | 1.4 (0-4.0) | 1.8 (0.6-2.9) | 0.5 (0-1.0) |
Spain | 10.1 (7.1-13.2) | 34.8 (30.2-39.4) | 32.2 (27.6-36.7) | 9.0 (6.2-11.9) | 1.8 (0.9-2.8) | 0.1 (0-0.2) | 3.8 (2.6-5.1) | 8.8 (3.3-14.4) |
Sweden | 78.1 (70.6-85.5) | 6.8 (3.5-10.2) | 0 (0-0) | 2.9 (0.7-5.1) | 0 (0-0) | 6.8 (0.3-11.0) | 2.1 (0.1-4.2) | 3.2 (0.9-5.6) |
After intervention (95% CI)* | ||||||||
Argentina | 31.2 (22.6-39.8) | 40.1 (26.6-53.6) | 8.1 (3.5-12.7) | 2.0 (0-4.2) | 0.5 (0-1.2) | 0.3 (0-1.0) | 0.5 (0-1.2) | 22.4 (7.2-37.7) |
Denmark | 83.7 (79.4-87.9) | 10.0 (6.2-13.9) | 2.0 (0.2-3.9) | 3.0 (1.7-4.5) | 0.3 (0-0.8) | 0 (0-0) | 0 (0-0) | 1.2 (0.1-2.2) |
Lithuania | 68.5 (58.5-78.6) | 17.6 (8.4-26.8) | 2.8 (1.2-4.3) | 7.9 (4.0-11.7) | 0 (0-0) | 0.5 (0-1.4) | 0.5 (0-1.4) | 2.3 (0-6.1) |
Russia | 19.4 (8.8-30.1) | 55.0 (43.5-66.4) | 12.8 (5.2-20.4) | 5.7 (0-12.5) | 0 (0-0) | 0.9 (0-2.1) | 4.3 (0.7-7.8) | 1.9 (0-4.5) |
Spain | 31.0 (26.2-35.9) | 29.8 (25.0-34.5) | 26.4 (22.0-30.7) | 4.7 (2.9-6.4) | 1.7 (0.7-2.6) | 0 (0-0) | 2.7 (1.3-4.1) | 4.1 (1.1-7.2) |
Sweden | 75.9 (70.2-81.7) | 7.1 (3.7-10.7) | 1.2 (0-2.7) | 3.8 (1.3-6.3) | 0 (0-0) | 6.7 (3.4-10.1) | 2.5 (0.5-4.6) | 2.9 (1.1-4.8) |